Free Trial

Connect Biopharma (CNTB) Institutional Ownership

Connect Biopharma logo
$2.40 +0.00 (+0.13%)
Closing price 03:59 PM Eastern
Extended Trading
$2.37 -0.03 (-1.37%)
As of 04:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Connect Biopharma (NASDAQ:CNTB)

Current
Institutional Ownership
Percentage
58.72%
Number of
Institutional Buyers
(last 12 months)
17
Total
Institutional Inflows
(last 12 months)
$7.09M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$3.63M
Get CNTB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Connect Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CNTB Institutional Buying and Selling by Quarter

Connect Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE15,673$41K0.0%N/A0.025%
5/18/2026 ADAR1 Capital Management LLC742,400$1.95M0.1%N/A1.179%
5/14/2026 Renaissance Technologies LLC120,700$316K0.0%-15.7%0.192%
5/14/2026 Knott David M Jr387,835$1.02M0.6%+93.9%0.686%
4/27/2026 Simplify Asset Management Inc.51,475$135K0.0%N/A0.091%
2/18/2026 Perceptive Advisors LLC792,696$2.24M0.0%N/A1.418%
2/18/2026 Millennium Management LLC47,050$133K0.0%N/A0.084%
2/17/2026 Royal Bank of Canada40,400$114K0.0%N/A0.072%
2/17/2026 Persistent Asset Partners Ltd26,774$76K0.0%N/A0.048%
2/16/2026 OMERS ADMINISTRATION Corp80,808$228K0.0%N/A0.145%
2/13/2026 Marshall Wace LLP128,368$362K0.0%+121.2%0.230%
2/12/2026 Jane Street Group LLC82,226$232K0.0%N/A0.147%
2/12/2026 HRT Financial LP16,785$47K0.0%+60.5%0.030%
2/12/2026 Renaissance Technologies LLC143,100$404K0.0%-9.5%0.256%
2/12/2026 Knott David M Jr200,000$564K0.3%N/A0.358%
2/12/2026 Richmond Brothers Inc.173,485$489K0.3%N/A0.310%
2/12/2026 SmartHarvest Portfolios LLC12,897$36K0.0%N/A0.023%
2/3/2026 BML Capital Management LLC408,887$1.15M1.0%-67.7%0.731%
11/10/2025 BML Capital Management LLC1,267,500$1.91M1.5%-30.4%2.275%
8/12/2025 XTX Topco Ltd28,862$29K0.0%N/A0.052%
8/12/2025 AlphaCore Capital LLC80,000$78K0.0%N/A0.144%
8/11/2025 BML Capital Management LLC1,821,558$1.79M1.4%-13.0%3.278%
7/29/2025 Koa Wealth Management LLC49,600$49K0.0%N/A0.089%
2/13/2025Renaissance Technologies LLC134,697$186K0.0%-23.2%0.244%
2/3/2025Callan Capital LLC80,000$110K0.0%+91.3%0.145%
1/27/2025Choreo LLC160,867$204K0.0%N/A0.291%
1/24/2025Catalina Capital Group LLC47,867$66K0.0%N/A0.087%
11/5/2024BML Capital Management LLC2,093,232$3.01M1.8%+2.4%3.789%
8/9/2024Renaissance Technologies LLC212,300$323K0.0%-11.5%0.385%
7/17/2024Keudell Morrison Wealth Management32,200$49K0.0%+63.5%0.058%
5/7/2024Keudell Morrison Wealth Management19,700$34K0.0%+75.9%0.036%
1/30/2024BML Capital Management LLC2,061,438$2.43M1.8%N/A3.743%
8/15/2023Kynam Capital Management LP535,005$603K0.1%-27.7%0.972%
11/14/2022Boothbay Fund Management LLC26,867$35K0.0%-65.5%0.049%
8/16/2022DAFNA Capital Management LLC250,000$218K0.1%N/A0.454%
5/13/2022Kynam Capital Management LP227,759$688K0.2%N/A0.414%
2/15/2022DLD Asset Management LP121,707$627K0.0%N/A0.212%
2/15/2022Adage Capital Partners GP L.L.C.1,250,000$6.44M0.0%N/A2.174%
2/14/2022Altium Capital Management LP175,000$901K0.2%N/A0.304%
2/11/2022Ensign Peak Advisors Inc25,412$131K0.0%N/A0.044%
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today


CNTB Institutional Ownership - Frequently Asked Questions

During the previous two years, 23 institutional investors and hedge funds held shares of Connect Biopharma. The most heavily invested institutionals were Perceptive Advisors LLC ($2.24M), ADAR1 Capital Management LLC ($1.95M), BML Capital Management LLC ($1.15M), Knott David M Jr ($1.02M), Richmond Brothers Inc. ($489K), Marshall Wace LLP ($362K), and Renaissance Technologies LLC ($316K).Learn more on Connect Biopharma's institutional investors.

58.72% of Connect Biopharma's stock is owned by institutional investors. Learn more on CNTB's institutional investor holdings.

Of the 22 institutional investors that purchased Connect Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Perceptive Advisors LLC ($792.70K), ADAR1 Capital Management LLC ($742.40K), Knott David M Jr ($387.84K), Richmond Brothers Inc. ($173.49K), Choreo LLC ($160.87K), Jane Street Group LLC ($82.23K), and OMERS ADMINISTRATION Corp ($80.81K).

Institutional investors have bought a total of 2,688,846 shares in the last 24 months. This purchase volume represents approximately $7.09M in transactions.

The following institutional investors have sold Connect Biopharma stock in the last 24 months: BML Capital Management LLC ($1.68M), and Renaissance Technologies LLC ($37.50K).

Institutional investors have sold a total of 1,721,845 shares in the last 24 months. This volume of shares sold represents approximately $3.63M in transactions.



This page (NASDAQ:CNTB) was last updated on 5/28/2026 by MarketBeat.com Staff.
From Our Partners